BIOMAT Database Logo BIOMAT Database Logo

Intramuscular versus subcutaneous injection for hepatitis B vaccine. 1988

C Fessard, and O Riche, and J H Cohen

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013810 Therapeutic Equivalency The relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease. Bioequivalence,Clinical Equivalency,Equivalency, Therapeutic,Generic Equivalency,Clinical Equivalencies,Equivalencies, Clinical,Equivalencies, Therapeutic,Equivalency, Clinical,Therapeutic Equivalencies,Bioequivalences,Equivalencies, Generic,Equivalency, Generic,Generic Equivalencies
D014761 Viral Hepatitis Vaccines Any vaccine raised against any virus or viral derivative that causes hepatitis. Hepatitis, Viral, Vaccines,Hepatitis Vaccines, Viral,Vaccines, Viral Hepatitis
D017325 Hepatitis B Vaccines Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced. Hepatitis B Vaccine,Vaccine, Hepatitis B,Vaccines, Hepatitis B

Related Publications

C Fessard, and O Riche, and J H Cohen
[Hepatitis B vaccine: GenHevac B Pasteur suspension for intramuscular injection].
February 1989, Revue de l'infirmiere,
C Fessard, and O Riche, and J H Cohen
Subcutaneous versus intramuscular administration of Haemophilus influenzae type b vaccine.
April 1989, Journal of the Royal Society of Health,
C Fessard, and O Riche, and J H Cohen
Safety of intramuscular injection of hepatitis B vaccine in haemophiliacs.
June 1990, BMJ (Clinical research ed.),
C Fessard, and O Riche, and J H Cohen
Injection site leakage of depot neuroleptics: intramuscular versus subcutaneous injection.
June 1987, The Journal of clinical psychiatry,
C Fessard, and O Riche, and J H Cohen
Epinephrine absorption in adults: intramuscular versus subcutaneous injection.
November 2001, The Journal of allergy and clinical immunology,
C Fessard, and O Riche, and J H Cohen
Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents.
April 1999, Vaccine,
C Fessard, and O Riche, and J H Cohen
Subcutaneous administration of inactivated hepatitis B vaccine by automatic jet injection.
January 1983, Journal of medical virology,
C Fessard, and O Riche, and J H Cohen
Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response.
January 1987, Scandinavian journal of infectious diseases,
C Fessard, and O Riche, and J H Cohen
Deltoid versus buttock as preferred site of injection for hepatitis B vaccine.
April 1989, The Journal of the Florida Medical Association,
C Fessard, and O Riche, and J H Cohen
Intramuscular versus intradermal hepatitis B vaccination.
August 1986, The New Zealand medical journal,
Copied contents to your clipboard!